Rigel Pharma (RIGL) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $38.72 --0%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
CRMT, PKE, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Solstice acquiring Element Solutions in $14.5B cash and stock deal
- Proto Labs (PRLB) PT Raised to $91 at Benchmark on Meeting and Exceeding Previous Target
- Middleby completes spin-off of food processing unit as Midera
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
